-+ 0.00%
-+ 0.00%
-+ 0.00%

Sensei Biotherapeutics director Stephen M. Hahn files initial beneficial ownership statement

PUBT·06/16/2026 20:19:33
Listen to the news
Sensei Biotherapeutics director Stephen M. Hahn files initial beneficial ownership statement
  • Sensei Biotherapeutics director Stephen M. Hahn reported holding 44,763 shares underlying Series B Preferred Stock in an initial Form 3 filing dated June 12, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensei Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002137706-26-000002), on June 16, 2026, and is solely responsible for the information contained therein.